N/A N=29 Supportive Care

CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology

Cancer

Bottom Line

View on ClinicalTrials.gov: NCT03302767 ↗

Enrolled (actual)

Serious AEs

—

Results posted

May 2021

Primary outcome: Primary: Quality of Life : EORTC QLQ-C30 Scores — 61.0; 70.8; 82.9; 83.2 scores on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Psychological and Social Consultation (Other)
Age: Adult · 25+ yrs
Sex: All
Sponsor: Institut Bergonié
Primary completion: Jun 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Quality of Life : EORTC QLQ-C30 Scores	61.0; 70.8; 82.9; 83.2; 72.6; 78.6	—
PRIMARY Cognitive Complaints : FACT Cog Scale Scores	39; 50.5; 8; 14.0; 15; 16	—
PRIMARY Professional Recovery Scale Scores	58; 61; 40.5; 50; 58.5; 60	—
SECONDARY Tiredness : Piper MFI-20 Scale Scores	5.4; 4.7; 5.3; 5.7; 4.2; 4.0	—
SECONDARY Anxio-depressive Troubles : HAD Scale Scores	10.0; 8; 7.0; 6.5	—

Summary

This patient support system is designed to help patients regain their professional activity after their treatment. It's a 3-Axis neuropsycho-social synergy on 3 axes: * A weekly pluridisciplinary consultation in tandem (Social worker + Psychologist / Neuropsychologist) * Monthly information meetings and workshops (TIC'Onco reunions: collective information times and Cogit'Onco workshops: cognitive workshops * An information booklet "Prepare the work return" The aim of this research is to evaluate efficiency in term of quality of life improvement linked to work status, utility, feasibility and patients' satisfaction. The aim of this research is to evaluate efficiency in term of quality of life improvement linked to work status, utility, feasibility and patients' satisfaction.

Eligibility Criteria

Inclusion Criteria

Patients attending the Institut Bergonié
Informed Consent signed.
Patients affiliated to a French social
living in Gironde
Professional activity at the time of diagnosis
Treated for - breast cancer, Hodgkin's or non-Hodgkin's lymphoma (non-cerebral), testicular cancer
CURATIVE support
At any time during treatment (chemotherapy or radiotherapy, or immunotherapy)

Exclusion Criteria

Patient deprived of liberty or subject to a legal protection measure
History of cancers
Cerebral pathology and / or brain metastasis

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03302767). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.